This rating was issued on 12/09/16. JPMorgan Chase & Co. lifted their target price on shares of Pagegroup PLC from GBX 360 ($4.47) to GBX 390 ($4.84) and gave the stock an underweight rating in a research report on Thursday, March 9th. Barclays PLC's price target points to a potential downside of 16.92% from the company's current price. There may be various price targets for a stock.
Several investment firms issued their expert ratings on AstraZeneca PLC (AZN) in which PiperJaffray Initiates Coverage on AstraZeneca PLC (AZN) to Overweight with no specific Price Target on 9/23/16. Exane BNP Paribas Downgrades the stock to Neutral on 9/14/16 with no specific Price Target.
4/10/2017-Jefferies Group LLC Reiterated Rating of Buy.
AstraZeneca PLC (AZN) now has a consensus Price Target of $32.14. While some analysts have a High Price target for the stock of $47.01 and a Low Price Target of $21.23.
A number of other equities research analysts also recently issued reports on SGE.
Trump signs order to implement 'Buy American, Hire American'
Industry experts believe this may harm companies like Infosys and Tata Consultancy Services that outsource those jobs to India. That takes work away from Americans, lowers wages and keeps Americans from being trained in tech-related fields, they say.
The stock diminished about -7.08% in the past 5 years, this negative value indicates that the stock constantly going down in previous years as well.
Over the last twelve months Tesco PLC's share price has increased from 181 to 182.66, changing by 0.92%.
BP plc is an integrated oil and gas company. The difference between Actual EPS and Estimated EPS was 0.02 Percent. The stock's market capitalization is GBX 644.46 million. The stock was bought at an average cost of GBX 354 ($4.42) per share, for a total transaction of £4,956 ($6,184.95). Barclays PLC reissued an equal weight rating and issued a GBX 410 ($5.09) target price on shares of Pagegroup PLC in a research report on Monday, January 30th. Pagegroup PLC has a 12 month low of GBX 156.30 and a 12 month high of GBX 494.50. The company's 50 day moving average price is GBX 428.81 and its 200 day moving average price is GBX 398.20. The Moving Average SMA50 is 3.28% while SMA200 is 3.78%. The Return on Investment (ROI) is at 15% while it's Return on Equity (ROE) value stands at 24.9%. The stock now shows its YTD (Year to Date) performance of 14.59 percent while its Weekly performance value is -2.7%. The Monthly and Yearly performances are 2.5 percent and 7.72 percent respectively.
AstraZeneca PLC (AZN) belongs to the "Healthcare" sector with an industry focus on "Drug Manufacturers - Major", with Mr. Pascal Soriot as Chief Exec. Officer and Exec. Director. For the next quarter the company has anticipated average revenues of $5.17B, according to the sentiments of 3 analysts.
On 2/10/2015 AstraZeneca plc announced a semiannual dividend of $1.90 5.57% with an ex dividend date of 2/18/2015 which will be payable on 3/23/2015.